Author/Editor		Kores-Plesničar, Blanka
Title		Sociodemografsko pomembne psihiatrične motnje in njihovo psihofarmakološko zdravljenje
Translated title		Sociaodemographis important psychiatric disorders and their phychopharmacological treatment
Type		članek
Source		Farm Vestn
Vol. and No.		Letnik 51, št. Spec issue
Publication year		2000
Volume		str. 207-13
Language		slo
Abstract		The defining factors of good treatment of psychiatric disorders, be it alone or in comorbidity with other disorders, will undoubtedly undergo further changes, most likely due to the discovery of some ultra-new class of psychotropic drugs in the future. The question remains, however, whether this alone will improve the treatment quality without close co-operation of doctors (who prescribe a certain drug), pharmacists (who issue the exactly same drug) and patients (who take the prescribed drug exactly as instructed). In order to improve the prediction of the treatment outcome in view of using different drugs and dosage, to intensify the follow-up of those patients whose condition has not improved (including searching for reasons) and to assure active following and monitoring of patients, it is of vital importance that an integral connection of all the participants in this process, which also includes patients education and activation through cooperation, providing information and delivery of care, be established.
Summary		Dejavniki, ki opredeljujejo dobro zdravljenje samostojnih ali komorbidnih psihiatričnih motenj se bodo v prihodnosti z razvojem kakšnega ultra novega razreda psihotropnih zdravil še spreminjali. Vprašanje ostaja ali se bo to zdravljenje brez prepotrebnega sodelovanja zdravnika (ki zdravilo predpiše), farmacevta (ki predpisano zdravilo izda) in bolnika (ki predpisano zdravilo jemlje) tudi v resnici izboljšalo. Vsi sodelujoči v tem procesu morajo biti integralno povezani in si zaupati, kar omogoča natančnejšo oceno izhoda zdravljenja, intenzivno spremljanje bolnikov, pri katerih se stanje ni izboljšalo (tudi iskanje vzrokov) ter zagotovilo aktivnega spremljanja in nadzorovanja zdravljenja. To pomeni tudi edukacijo bolnikov in njihovo aktivacijo v procesu zdravljenja v smislu sodelovanja in zagotavljanja informacij.
Descriptors		DEPRESSIVE DISORDER ANTIDEPRESSIVE AGENTS ALZHEIMER'S DISEASE PATIENT COMPLIANCE